BlackRock Fund Advisors’s Epizyme, Inc EPZM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$24.4M Buy
2,015,105
+216,376
+12% +$2.26M ﹤0.01% 2070
2016
Q3
$17.7M Buy
1,798,729
+109,415
+6% +$999K ﹤0.01% 2135
2016
Q2
$17.3M Sell
1,689,314
-9,202
-0.5% -$103K ﹤0.01% 2108
2016
Q1
$20.6M Buy
1,698,516
+502,627
+42% +$5.08M ﹤0.01% 1978
2015
Q4
$19.2M Sell
1,195,889
-82,176
-6% -$1.22M ﹤0.01% 2070
2015
Q3
$16.4M Buy
1,278,065
+55,334
+5% +$1.12M ﹤0.01% 2114
2015
Q2
$29.3M Buy
1,222,731
+397,649
+48% +$7.65M 0.01% 1871
2015
Q1
$15.5M Buy
825,082
+94,042
+13% +$1.94M ﹤0.01% 2202
2014
Q4
$13.8M Buy
731,040
+42,527
+6% +$993K ﹤0.01% 2266
2014
Q3
$18.7M Buy
688,513
+13,878
+2% +$431K 0.01% 1996
2014
Q2
$21M Buy
674,635
+105,568
+19% +$2.49M 0.01% 1991
2014
Q1
$13M Buy
569,067
+97,947
+21% +$2.97M ﹤0.01% 2241
2013
Q4
$9.8M Buy
471,120
+318,975
+210% +$9.25M ﹤0.01% 2404
2013
Q3
$6.09M Buy
152,145
+18,237
+14% +$618K ﹤0.01% 2663
2013
Q2
$3.77M Buy
+133,908
New +$3.44M ﹤0.01% 2876

Other funds holding EPZM